<DOC>
	<DOCNO>NCT01090713</DOCNO>
	<brief_summary>The specific aim study examine efficacy safety lisdexamfetamine compare placebo outpatient binge eat disorder</brief_summary>
	<brief_title>Efficacy Study Lisdexamfetamine Treat Binge Eating Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Patients meet DSMIV criterion BED least last 6 month Women pregnant lactate woman childbearing potential take adequate contraceptive measure . If possibility female subject might pregnant , pregnancy test perform . ( All woman childbearing potential negative pregnancy test enter study . ) Subjects display clinically significant suicidality homicidality . A current recent ( within 6 month start study medication ) DSMIV diagnosis substance abuse dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>